ai-for-science
AI Is Rewriting the Odds of Drug Development
a16z argues AI could alter drug hit rates and development timelines, but without clinical validation it remains a commercial option, not a proven infl
1 article tagged with this topic
a16z argues AI could alter drug hit rates and development timelines, but without clinical validation it remains a commercial option, not a proven infl